Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs aimed toward expanding the horizons of cytokine-based immunotherapy, specifically for cancers where cure possibilities remain limited. Use the links below to learn much more about our portfolio of cytokine-based immunotherapy candidates. Take a look https://financefeeds.com/guavapay-appoints-guy-noble-as-new-ceo/